Mati completes Nepafenac Evolute phase 2 clinical trial in cataract surgery patients
Mati Therapeutics has completed a phase II clinical trial to evaluate the safety and efficacy of nepafenac delivered…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
08 May 19
Mati Therapeutics has completed a phase II clinical trial to evaluate the safety and efficacy of nepafenac delivered…
06 May 19
comenityMED is all set to launch its debut women’s healthcare product Resilient Professional Foot Supports for use with…
03 May 19
Atia Vision, a Shifamed portfolio company committed to improving patient outcomes through the development of a modular presbyopia-correcting…
30 Apr 19
Eyenuk has announced results of its multi-center, pivotal clinical trial to validate the EyeArt AI Eye Screening System…
29 Apr 19
ZEISS Medical Technology Segment launched the first dual-speed Swept-Source OCT/OCTA that will now scan at 200kHz, in addition…
29 Apr 19
Santen Pharmaceutical’s US subsidiary and Glaukos have entered into collaboration and distribution agreement for exclusive distribution of MicroShunt…
29 Apr 19
Oculos, a vertically-integrated ophthalmic R&D organization, and Optceutics, an expert in ophthalmic R&D, have signed a co-promotion agreement…
22 Apr 19
American medical devices company Visioneering Technologies (VTI) and ophthalmic products developer Lambda-X have developed customized software that can…
17 Apr 19
Huawei has partnered with medical research bodies IIS Aragon and DIVE Medical to launch Track AI, an AI-powered…
12 Apr 19
LumiThera, a company developing treatment for ocular diseases, has started enrolling patients for LIGHTSITE II, a multi-center, clinical…